These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23163034)

  • 1. [Study of cross-activity of Streptococcus pneumoniae antigen preparations].
    Vaneeva NP; Vorob'ev DS; Grishchenko NV; Kurbatova EA; Iastrebova NE; Kalina NG; Elkina SI; Zubkov AV; Aparin PG; L'vov VL; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (5):36-42. PubMed ID: 23163034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [STUDY OF PROTECTIVE ACTIVITY OF PROTEIN-CONTAINING ANTIGENS OF STREPTOCOCCUS PNEUMONIAE IN A HETEROLOGOUS SYSTEM].
    Vorobiev DS; Semenova IB; Volokh YV; Romanenko EE; Baturo AP; Mikhailova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):51-5. PubMed ID: 26950989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Strain differences of intra-species immunogenic activity of Streptococcus pneumoniae antigen components].
    Kurbatova EA; Vorob'ev DS; Egorova NB; Baturo AP; Romanenko ÈE; Markova ME; Elkina SI; Volokh IuV; Tsvetkov IuE; Sukhova EV; Iashunskiĭ DV; Nifant'ev NÈ; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (5):60-9. PubMed ID: 24605656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of protective activity of Streptococcus pneumoniae protein-containing antigen complex in homologous system].
    Vorob'ev DS; Semenova IB; Volokh IuV; Kudriashev AV; Markova ME; Romanenko ÉE; Baturo AP; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (1):21-6. PubMed ID: 23805647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides.
    Denoël P; Godfroid F; Hermand P; Verlant V; Poolman J
    Vaccine; 2011 Sep; 29(38):6451-3. PubMed ID: 21315695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies.
    Choi EH; Zhang F; Lu YJ; Malley R
    Clin Vaccine Immunol; 2016 Feb; 23(2):162-7. PubMed ID: 26677201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Synthesis of Truncated Capsular Oligosaccharide of Serotypes 6C and 6D of
    Mettu R; Cheng YY; Vulupala HR; Lih YH; Chen CY; Hsu MH; Lo HJ; Liao KS; Chiu CH; Wu CY
    ACS Infect Dis; 2024 Jun; 10(6):2161-2171. PubMed ID: 38770797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience of application of pneumococcus vaccines for studies of humoral immunity].
    Iastrebova NE; Grishchenko NV; Kostinov MP; Salkina OA; Snegova NV; Vaneeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (2):96-101. PubMed ID: 23805679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-molecular antigenic complex of the pneumococcus: its properties].
    Rodionychev EA; Krasnoproshina LI; Padiukov LN; Tsvetkova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):23-8. PubMed ID: 3993288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production, binding characteristics and protective immunity of monoclonal antibody to pneumococcal type-9V conjugate.
    Lee CJ; Karpas A; Wang TR; Kosaka T; Koizumi K
    Microbiol Immunol; 1996; 40(11):857-65. PubMed ID: 8985941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of strain-producer and cultivation medium on cross antigenic activity of Streptococcus pneumoniae water soluble antigens].
    Kurbatova EA; Vorob'ev DS; Egorova NB; Elkina SI; Kalina NG; Tokarskaia MM; Baturo AP; Romanenko ÉE; Markova ME; Grishchenko NV; Ovechko NN; Volokh IuV; Zlygostev SA; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (1):26-33. PubMed ID: 23805648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies.
    Spencer BL; Shenoy AT; Orihuela CJ; Nahm MH
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
    Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and mechanisms of action of PnuBioVax, a multi-antigen serotype-independent prophylactic vaccine against infection with Streptococcus pneumoniae.
    Hill S; Entwisle C; Pang Y; Joachim M; McIlgorm A; Dalton K; Burbidge P; Colaco C; Brown J; Goldblatt D; Bailey C
    Vaccine; 2018 Jul; 36(29):4255-4264. PubMed ID: 29895498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.